These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36442459)

  • 1. A liquid chromatography-tandem mass spectrometry method for simultaneous quantification of thirty-nine tyrosine kinase inhibitors in human plasma.
    Guo ZX; Wu YE; Shi HY; van den Anker J; Liang P; Zheng Y; Zhao XW; Feng R; Zhao W
    J Pharm Biomed Anal; 2023 Feb; 224():115159. PubMed ID: 36442459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC-MS/MS for therapeutic drug monitoring.
    Zhang M; Liu X; Chen Z; Jiang S; Wang L; Tao M; Miao L
    J Pharm Biomed Anal; 2022 Mar; 211():114562. PubMed ID: 35124453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of three tyrosine kinase inhibitors and three triazoles in human plasma by LC-MS/MS: applications to therapeutic drug monitoring and drug-drug interaction studies.
    Li N; Liu L; Liu D; Yu H; Yang G; Qiu L; Chen Y; Xiang D; Gong X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Oct; 1246():124276. PubMed ID: 39208604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous and rapid determination of 12 tyrosine kinase inhibitors by LC-MS/MS in human plasma: Application to therapeutic drug monitoring in patients with non-small cell lung cancer.
    Zhou L; Wang S; Chen M; Huang S; Zhang M; Bao W; Bao A; Zhang P; Guo H; Liu Z; Xie G; Gao J; Wu Z; Lou Y; Fan G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1175():122752. PubMed ID: 33991955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of an LC-MS/MS assay for rapid and simultaneous quantification of 21 kinase inhibitors in human plasma and serum for therapeutic drug monitoring.
    Al Shirity ZN; Westra N; Hateren KV; Munnink THO; Kosterink JGW; Mian P; Hooge MNL; Touw DJ; Gareb B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Sep; 1229():123872. PubMed ID: 37716342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to therapeutic drug monitoring.
    Koller D; Vaitsekhovich V; Mba C; Steegmann JL; Zubiaur P; Abad-Santos F; Wojnicz A
    Talanta; 2020 Feb; 208():120450. PubMed ID: 31816725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of selected tyrosine kinase inhibitors with corticosteroids and antiemetics in rat plasma by solid phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic interaction studies.
    Maher HM; Alzoman NZ; Shehata SM
    J Pharm Biomed Anal; 2016 May; 124():216-227. PubMed ID: 26966895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
    Aghai F; Zimmermann S; Kurlbaum M; Jung P; Pelzer T; Klinker H; Isberner N; Scherf-Clavel O
    Anal Bioanal Chem; 2021 Jan; 413(2):599-612. PubMed ID: 33155133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a novel LC-MS/MS method for simultaneous quantitative determination of tyrosine kinase inhibitors in human plasma.
    Lou Y; Qin H; Hu Q; Chai Y; Zhou H; Chen M; Wang Q; Huang P; Gu J; Zhang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Oct; 1208():123394. PubMed ID: 35932695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
    Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
    Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification and analyses of seven tyrosine kinase inhibitors targeting hepatocellular carcinoma in human plasma by QuEChERS and UPLC-MS/MS.
    Liang Y; Li Y; Song L; Zhen X; Peng J; Li H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul; 1242():124217. PubMed ID: 38924946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of eight hematological tyrosine kinase inhibitors in both plasma and whole blood by a validated LC-MS/MS method.
    Verougstraete N; Stove V; Verstraete AG; Stove C
    Talanta; 2021 May; 226():122140. PubMed ID: 33676691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous quantitative determination of seven novel tyrosine kinase inhibitors in plasma by a validated UPLC-MS/MS method and its application to human microsomal metabolic stability study.
    Ezzeldin E; Iqbal M; Herqash RN; ElNahhas T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1136():121851. PubMed ID: 31812004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of 5- fluorouracil, capecitabine and its metabolite concentrations in blood using volumetric absorptive microsampling technology and LC-MS/MS.
    Radovanovic M; Schneider JJ; Shafiei M; Martin JH; Galettis P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jan; 1188():123075. PubMed ID: 34891049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Novel Analytical Method for Determining Trazodone in Human Plasma by Liquid Chromatography Coupled With Mass Spectrometry Coupled With Automatic 2-Dimensional Liquid Chromatograph-Mass Spectrometer Coupler 9500 and Its Application to Therapeutic Drug Monitoring.
    Ding J; Zhang Y; Cui X; Zhao C; Zhang S
    Ther Drug Monit; 2022 Jun; 44(3):465-473. PubMed ID: 34469419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An automated method for the measurement of a range of tyrosine kinase inhibitors in human plasma or serum using turbulent flow liquid chromatography-tandem mass spectrometry.
    Couchman L; Birch M; Ireland R; Corrigan A; Wickramasinghe S; Josephs D; Spicer J; Flanagan RJ
    Anal Bioanal Chem; 2012 Jun; 403(6):1685-95. PubMed ID: 22526649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of a novel c-Met/AXL dual-target small-molecule inhibitor BPI-9016M and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry: Application in a pharmacokinetic study in Chinese advanced solid tumor patients.
    Cui X; Zheng X; Jiang J; Tan F; Ding L; Hu P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():33-40. PubMed ID: 29028616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of Osimertinib, Aumolertinib, and Furmonertinib in Human Plasma for Therapeutic Drug Monitoring by UPLC-MS/MS.
    Li Y; Meng L; Ma Y; Li Y; Xing X; Guo C; Dong Z
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and clinical application of a LC-MS/MS method for simultaneous determination of various tyrosine kinase inhibitors in human plasma.
    Götze L; Hegele A; Metzelder SK; Renz H; Nockher WA
    Clin Chim Acta; 2012 Jan; 413(1-2):143-9. PubMed ID: 21945732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.